Hyundai Motor shares hit record high on robotics lift

Hyundai Motor Group Robotics LAB’s DAL-e Delivery. (Hyundai Motor/Kia)

Hyundai Motor Co. extended its rally for a third consecutive trading day on Tuesday, setting a new intraday all-time high.

Shares of Hyundai Motor were trading at 393,500 won ($267) as of 9:39 a.m., up 7.22 percent from the previous session. During the day, the stock briefly climbed to 398,000 won, marking its highest level ever.

Gains in Hyundai Motor also lifted group affiliates.

Shares of Hyundai Mobis Co. were up 13.32 percent and Hyundai Autoever Corp. gained 12.83 percent, with both hitting new 52 week highs.

Shares of Kia Corp. were trading 3.02 percent higher.

The rally was attributed to improved investor sentiment after Hyundai Motor Group unveiled a range of artificial intelligence robotics products and technologies at Consumer Electronics Show 2026 in Las Vegas last week.

Target price upgrades by brokerages also helped fuel buying interest.

Eugene Investment & Securities Co. raised its target price on Hyundai Motor to 600,000 won, calling the company a key player in the era of physical AI.

Analyst Lee Jae-il said Hyundai Motor has reached a “turning point for a valuation re rating,” citing the unveiling of the humanoid robot New Atlas and deeper cooperation with Nvidia Corp.

Lee said the company’s valuation could rise to levels comparable with Toyota Motor Corp. or leading technology firms.

Kiwoom Securities Co. also lifted its target price to 450,000 won, forecasting a continued rally. The brokerage said all three of Hyundai Motor Group’s physical AI growth businesses robotics, robotaxis and software defined factories have begun to show clearer business direction and partnerships.

Meanwhile, U2Bio Co. hit the daily upper limit after news that it secured Daewoong Co. as a strategic investor.

U2Bio shares were trading at 5,490 won as of 9:33 a.m., up 29.94 percent from the previous session.

Investor sentiment was boosted after disclosures that Daewoong would participate in U2Bio’s capital increase. Regulatory filings on Monday showed that U2Bio will conduct a third party allocated capital increase.

Under the deal, U2Bio will receive 564,745 treasury shares held by Daewoong, valued at about 12.1 billion won, as an in kind contribution. In return, it will allocate 2,388,278 new shares to Daewoong through a third party allotment.

Daewoong’s investment is seen as aimed at strengthening its competitiveness in digital healthcare.

Earlier, Daewoong said at its New Year kickoff meeting that it aims to make 2026 a turning point to leap into a global healthcare company.

Shares of Hyundai Motor soared 10.63 percent to close at 406,000 won on Tuesday. Hyundai Mobis ended at 451,000 won, Hyundai Autoever at 501,000 won, and Kia at 136,000 won. U2Bio finished at 5,490 won.